Search research articles
Contact Us
Filters
Showing results (71-80 of 139) with videos related to
Page
of 14
Sort By:
The American Journal of Emergency Medicine
|
October 11, 2020
Development and validation of a knowledge-driven risk calculator for critical illness in COVID-19 patients
Amos Cahan, Tamar Gottesman, Michal Tzuchman Katz, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
June 3, 2018
Sarcopenic obesity: Time to meet the challenge
Rocco Barazzoni, Stephan C Bischoff, Yves Boirie, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 2, 2025
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1
Subodh Verma, Morten Böttcher, Paul Brown, et al.
Harefuah
|
December 12, 2019
[DIAGNOSIS, TREATMENT AND PREVENTION OF GASTROINTESTINAL DISEASES PRE AND POST BARIATRIC SURGERY PROCEDURES]
Nasser Sakran, Carmil Azran, Ilanit Mahler, et al.
Diabetes Care
|
February 21, 2023
Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
Hiddo J L Heerspink, Ellen Apperloo, Melanie Davies, et al.
Diabetes Care
|
March 7, 2020
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
W Timothy Garvey, Andreas L Birkenfeld, Dror Dicker, et al.
American Heart Journal
|
December 3, 2014
Multidisciplinary rehabilitation program in recently hospitalized patients with heart failure and preserved ejection fraction: rationale and design of a randomized controlled trial
Edward Koifman, Ehud Grossman, Avishay Elis, et al.
The Lancet. Diabetes & Endocrinology
|
October 2, 2025
Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
Filip K Knop, George Kunos, Dror Dicker, et al.
Obesity Surgery
|
November 24, 2018
Prediction of Long-Term Diabetes Remission After RYGB, Sleeve Gastrectomy, and Adjustable Gastric Banding Using DiaRem and Advanced-DiaRem Scores
Dror Dicker, Rachel Golan, Judith Aron-Wisnewsky, et al.
Advances in Therapy
|
November 28, 2025
Correction to: Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study
Esther Artime, Erik Spaepen, Sarah Zimner-Rapuch, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 139) with videos related to
Sort By:
Page
of 14
The American Journal of Emergency Medicine
|
October 11, 2020
Development and validation of a knowledge-driven risk calculator for critical illness in COVID-19 patients
Amos Cahan, Tamar Gottesman, Michal Tzuchman Katz, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
June 3, 2018
Sarcopenic obesity: Time to meet the challenge
Rocco Barazzoni, Stephan C Bischoff, Yves Boirie, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 2, 2025
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1
Subodh Verma, Morten Böttcher, Paul Brown, et al.
Harefuah
|
December 12, 2019
[DIAGNOSIS, TREATMENT AND PREVENTION OF GASTROINTESTINAL DISEASES PRE AND POST BARIATRIC SURGERY PROCEDURES]
Nasser Sakran, Carmil Azran, Ilanit Mahler, et al.
Diabetes Care
|
February 21, 2023
Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
Hiddo J L Heerspink, Ellen Apperloo, Melanie Davies, et al.
Diabetes Care
|
March 7, 2020
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
W Timothy Garvey, Andreas L Birkenfeld, Dror Dicker, et al.
American Heart Journal
|
December 3, 2014
Multidisciplinary rehabilitation program in recently hospitalized patients with heart failure and preserved ejection fraction: rationale and design of a randomized controlled trial
Edward Koifman, Ehud Grossman, Avishay Elis, et al.
The Lancet. Diabetes & Endocrinology
|
October 2, 2025
Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
Filip K Knop, George Kunos, Dror Dicker, et al.
Obesity Surgery
|
November 24, 2018
Prediction of Long-Term Diabetes Remission After RYGB, Sleeve Gastrectomy, and Adjustable Gastric Banding Using DiaRem and Advanced-DiaRem Scores
Dror Dicker, Rachel Golan, Judith Aron-Wisnewsky, et al.
Advances in Therapy
|
November 28, 2025
Correction to: Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study
Esther Artime, Erik Spaepen, Sarah Zimner-Rapuch, et al.
Page
of 14